extract from an article on Seeking Alpha
For the pediatric trial, however, there is really nothing left to discuss. The trial was a failure. How much of an effect the pediatric Rett data will have on the rest of the pipeline is anyone's guess, but for now, the stock has taken a terrible beating, going down losing 40% overnight.The company did try to explain the poor show by claiming a very strong placebo effect, but their reasons sounded hollow.
- Forums
- ASX - By Stock
- NEU
- ANAVEX MEETS ENDPOINTS PHASE2 RETT
ANAVEX MEETS ENDPOINTS PHASE2 RETT, page-167
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$21.80 |
Change
0.460(2.16%) |
Mkt cap ! $2.783B |
Open | High | Low | Value | Volume |
$21.50 | $22.27 | $21.49 | $17.34M | 792.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 3550 | $21.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.81 | 567 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 3550 | 21.800 |
1 | 1979 | 21.770 |
1 | 2572 | 21.760 |
1 | 5000 | 21.750 |
1 | 1979 | 21.740 |
Price($) | Vol. | No. |
---|---|---|
21.920 | 700 | 1 |
21.970 | 1979 | 2 |
22.000 | 2557 | 5 |
22.010 | 1979 | 1 |
22.040 | 50 | 1 |
Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
Last
$21.85 |
  |
Change
0.460 ( 2.27 %) |
|||
Open | High | Low | Volume | ||
$21.56 | $22.26 | $21.50 | 182893 | ||
Last updated 15.59pm 16/05/2024 ? |
Featured News
NEU (ASX) Chart |